GDNF and amyotrophic lateral sclerosis: Li-Jun Wang et al. conducted a similar study, demonstrating that bilateral intramuscular injection of the AAV-GDNF vector delayed disease onset by ~13% and prolonged the survival of ALS transgenic mice by ~14%.